Rapid and easy method for monitoring oxidative stress markers in body fluids of patients with asbestos or silica-induced lung diseases

Syslová, Kamila; Kačer, Petr; Kuzma, Marek; Najmanová, Věra; Fenclová, Zdeňka; Vlčková, Štěpánka; Lebedová, Jindřiška; Pelclová, Daniela

doi:10.1016/j.jchromb.2009.06.008

Cited by 70 publications

(71 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Analysis of 8-isoprostane, MDA and HNE was performed as previously described 5,15) . Briefly, the method consists of pre-treatment, solid-phase extraction for rapid and effective isolation of biomarkers from the biological matrices (EBC, plasma and urine) and a detection method using liquid chromatography -electrospray ionization -mass spectrometry/mass spectrometry (LC-ESI-MS/MS).…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Oxidative Stress Markers in Exhaled Breath Condensate in Lung Fibroses Are Not Significantly Affected by Systemic Diseases

et al. 2011

Self Cite

View full text Add to dashboard Cite

Exhaled breath condensate (EBC) is assumed to reflect processes in the lungs, yet itis unknown whether oxidative stress markers in EBC are affected by systemic disorders (atherosclerosis, hypertension, diabetes) or whether lung diseases increase markers in plasma and urine. 8-isoprostane, 4-hydroxy-trans-2-nonenale (HNE) and malondialdehyde (MDA) were measured using liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS/MS) in EBC, plasma and urine in 82 patients (45 with asbestosis and hyalinosis, and 37 with silicosis) and in 29 control subjects. 8-isoprostane and HNE in EBC, and HNE in urine were higher in both groups of patients. In addition, 8-isoprostane in plasma and urine, and MDA in urine were higher in asbestos-exposed patients and MDA in plasma in silicotics, with this marker in plasma correlated with the grade of silicosis. In all subjects, 8-isoprostane in EBC correlated with urine (r=0.38, p<0.001) and plasma levels (r=0.28, p=0.003), and HNE and MDA with urine levels (r=0.31, p<0.001; r=0.23, p=0.016, respectively). Most markers positively correlated with lung function impairment, EBC markers negatively with vitamin E supplementation. To conclude: The influence of satisfactorily controlled systemic disorders on markers in EBC in patients with pneumoconioses is not significant. In addition to oxidative stress markers in EBC, lung fibroses may increase oxidative stress markers in plasma and urine.

show abstract

Section: Methodsmentioning

confidence: 99%

“…The quantification of oxidative stress can also be assessed by the measurement of aldehydes, such as malondialdehyde (MDA) and 4-hydroxy-trans-2-nonenale (HNE). Except for our pilot study 5) , these markers have not yet been studied in EBC in a larger number of subjects with pneumoconioses.…”

Section: Introductionmentioning

confidence: 99%

Oxidative Stress Markers in Exhaled Breath Condensate in Lung Fibroses Are Not Significantly Affected by Systemic Diseases

et al. 2011

Self Cite

View full text Add to dashboard Cite

show abstract

“…Analysis of leukotrienes was performed as previously described 28) . Briefly, the method consists of a pretreatment step, solid-phase extraction (SPE) for rapid and effective isolation of biomarkers from the biological matrices (EBC, plasma and urine) and a detection method using Industrial Health 2012, 50, 299-306 liquid chromatography − electrospray ionization − tandem mass spectrometry (LC-ESI-MS/MS).…”

Section: Analysis Of Leukotrienesmentioning

confidence: 99%

Leukotrienes B4, C4, D4 and E4 in the Exhaled Breath Condensate (EBC), Blood and Urine in Patients with Pneumoconiosis

Pelclová¹,

Fenclová²,

Vlčková³

et al. 2012

Ind Health

Self Cite

View full text Add to dashboard Cite

Leukotrienes (LTs) are involved in the pathogenesis of lung fibrosis and were increased in exhaled breath condensate (EBC) of the patients with pneumoconiosis. However the possible influence of extra-pulmonary disorders on the EBC markers is not known. Therefore in parallel with EBC, LTs' levels in the plasma and urine were measured in patients with pneumoconiosis (45 × asbestos exposure, 37 × silica exposure) and in 27 controls. Individual LTs B4, C4, D4 and E4 were measured by liquid chromatography − electrospray ionization − tandem mass spectrometry (LC-ESI-MS/MS). In EBC, LT D4 and LT E4 were increased in both groups of patients (p<0.001 and p<0.05), comparing with the controls. Both LT B4 and cysteinyl LTs were elevated in asbestosexposed subjects (p<0.05). Asbestosis with more severe radiological signs (s1/s2-t3/u2) and lung functions impairment has shown higher cysteinyl LTs and LT C4 in the EBC (p<0.05) than mild asbestosis (s1/s0-s1/s1). In addition, in the subjects with asbestosis, cysteinyl LTs in EBC correlated with TLC (−0.313, p<0.05) and TLCO/Hb (−0.307, p<0.05), and LT C4 with TLC (−0.358, p<0.05). In pneumoconioses, EBC appears the most useful from the 3 fluids studied.

show abstract

“…Malondialdehyde is a by-product of this reaction and can be detected, for instance, in workers with occupational respiratory disease by using another method for quantifying the products of respiration: analysis of exhaled breath condensate. (16) Patients with asbestosis also present with increased inflammatory markers, such as hydrogen peroxide and elevated total protein levels. (17) In this technique, the air that is exhaled undergoes freezing or cooling.…”

Section: Discussionmentioning

confidence: 99%

Temperatura do ar exalado, um novo biomarcador no controle da asma: um estudo piloto

2010

View full text Add to dashboard Cite

Objective: To evaluate whether the exhaled breath temperature (EBT), measured by a noninvasive method, is an effective means of monitoring patients with uncontrolled asthma. Methods: A pilot study comprising nine patients (seven women and two men; mean age: 39 years) diagnosed with asthma at least one year prior to the beginning of the study and not having been under maintenance therapy for the last three months. In the first visit, the patients underwent spirometry and measurement of EBT. The patients were then instructed to use inhaled budesonide/formoterol (200/6 µg) every 12 h for six weeks. In addition, the patients with severe asthma (FEV 1 < 60% of predicted) were instructed to use oral prednisolone (40 mg/day) for five days. After six weeks, the patients underwent the same tests. Results: All of the patients reported an improvement in the symptoms of asthma, as confirmed by a statistically significant increase in FEV 1 from the first to the second visit (mean, 56.1% vs. 88.7% of predicted; p < 0.05). Five patients used oral prednisolone for the first five days of the treatment period. Six patients used additional doses of inhaled budesonide/formoterol (mean duration, 2.5 weeks). The EBT decreased significantly from the first to the second visit (mean EBT: 35.1°C vs. 34.1°C; p < 0.05). Conclusions: Uncontrolled asthma, especially during exacerbations, is followed by an increase in EBT, which decreases after appropriate asthma control, as demonstrated by an increase in FEV 1 and an improvement of the reported symptoms. These preliminary results suggest that EBT can be used as a parameter for the assessment of asthma control.Keywords: Asthma; Biomarkers, pharmacological; Hydroxycorticosteroids. ResumoObjetivo: Avaliar se a temperatura do ar exalado (TAE), medida por um método não invasivo, é efetiva no monitoramento de pacientes com asma não controlada. Métodos: Estudo piloto com nove pacientes (sete mulheres e dois homens; média de idade: 39 anos) com diagnóstico de asma por pelo menos um ano e sem uso de tratamento de manutenção por pelo menos três meses antes do início do estudo. Na primeira visita, os pacientes foram submetidos à espirometria e à medida da TAE. Todos os pacientes foram orientados a iniciar tratamento com budesonida/formoterol (200/6 µg) inalatório a cada 12 h por seis semanas. Além disso, os pacientes com asma grave (VEF 1 < 60% do previsto) foram orientados a utilizar prednisolona oral (40 mg/dia) por cinco dias. Após seis semanas, os pacientes foram submetidos aos mesmos testes. Resultados: Todos os pacientes relataram melhora dos sintomas de asma; confirmada por um aumento significativo de VEF 1 da primeira para a segunda visita (média de VEF 1 : 56,1% vs. 88,7% do previsto; p < 0,05). Cinco pacientes utilizaram prednisolona oral, mas somente nos cinco dias iniciais do tratamento. Seis pacientes utilizaram doses extras da medicação inalatória (média de tempo de uso de medicação adicional = 2,5 semanas). Houve uma diminuição significativa da TAE entre os momentos de avaliação ...

show abstract

Rapid and easy method for monitoring oxidative stress markers in body fluids of patients with asbestos or silica-induced lung diseases

Cited by 70 publications

References 19 publications

Oxidative Stress Markers in Exhaled Breath Condensate in Lung Fibroses Are Not Significantly Affected by Systemic Diseases

Oxidative Stress Markers in Exhaled Breath Condensate in Lung Fibroses Are Not Significantly Affected by Systemic Diseases

Leukotrienes B4, C4, D4 and E4 in the Exhaled Breath Condensate (EBC), Blood and Urine in Patients with Pneumoconiosis

Temperatura do ar exalado, um novo biomarcador no controle da asma: um estudo piloto

Contact Info

Product

Resources

About